Pierce; Kristen

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pierce; Kristen.The latest application filed is for "afucosylated anti-fgfr2iiib antibodies".

Company Profile

2.3.12

Pierce; Kristen - Burlingame CA
Pierce; Kristen - San Francisco CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
FGFR2 inhibitors alone or in combination with immune stimulating agents in cancer treatment Grant 11,447,553 - Pierce , et al. September 20, 2	2022-09-20
Afucosylated Anti-FGFR2IIIB Antibodies App 20220168416 - Harding; Thomas ; et al.	2022-06-02
Afucosylated anti-FGFR2IIIB antibodies Grant 11,235,059 - Harding , et al. February 1, 2	2022-02-01
Cd80 Extracellular Domain Fc Fusion Protein Dosing Regimens App 20210340214 - INAMDAR; Sandeep P. ; et al.	2021-11-04
Afucosylated Anti-FGFR2IIIB Antibodies App 20190175730 - Harding; Thomas ; et al.	2019-06-13
Method of treatment of malignant solid tumors with afucosylated anti-FGFR2IIIb antibodies Grant 10,172,937 - Harding , et al. J	2019-01-08
Predicting Response To Cancer Treatment With Fgfr2 Inhibitors App 20170145103 - Pierce; Kristen ; et al.	2017-05-25
Fgfr2 Inhibitors Alone Or In Combination With Immune Stimulating Agents In Cancer Treatment App 20170145102 - Pierce; Kristen ; et al.	2017-05-25
Afucosylated Anti-fgfr2iiib Antibodies App 20160339100 - Harding; Thomas ; et al.	2016-11-24
Afucosylated Anti-fgfr2iiib Antibodies App 20150050273 - Harding; Thomas ; et al.	2015-02-19
Compositions And Methods For Regulating Collagen And Smooth Muscle Actin Expression By Serpine2 App 20100183620 - BHAWE; KAUMUDI ; et al.	2010-07-22
Pharmaceutical Compositions Containing Antagonists to Lrp4, Lrp8 or Megalin for Treatment of Diseases App 20080254033 - Pierce; Kristen ; et al.	2008-10-16
Method of Producing Autologous Embryonic Stem Cells App 20080112937 - Williams; Lewis T ; et al.	2008-05-15
Lung-Expressed Polypeptides App 20080014594 - Hestir; Kevin ; et al.	2008-01-17
Fibroblast Growth Factor Receptors 1,2,3, and 4 as Targets for Therapeutic Intervention App 20070248605 - Hestir; Kevin ; et al.	2007-10-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.